These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27644598)

  • 1. Sex-related differential susceptibility to doxorubicin-induced cardiotoxicity in B6C3F
    Jenkins GR; Lee T; Moland CL; Vijay V; Herman EH; Lewis SM; Davis KJ; Muskhelishvili L; Kerr S; Fuscoe JC; Desai VG
    Toxicol Appl Pharmacol; 2016 Nov; 310():159-174. PubMed ID: 27644598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of doxorubicin-induced chronic cardiotoxicity in the B6C3F1 mouse model.
    Desai VG; Herman EH; Moland CL; Branham WS; Lewis SM; Davis KJ; George NI; Lee T; Kerr S; Fuscoe JC
    Toxicol Appl Pharmacol; 2013 Jan; 266(1):109-21. PubMed ID: 23142469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candidate early predictive plasma protein markers of doxorubicin-induced chronic cardiotoxicity in B6C3F
    Desai VG; Lee T; Moland CL; Vijay V; Han T; Lewis SM; Herman EH; Fuscoe JC
    Toxicol Appl Pharmacol; 2019 Jan; 363():164-173. PubMed ID: 30517846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early metabolomics changes in heart and plasma during chronic doxorubicin treatment in B6C3F1 mice.
    Schnackenberg LK; Pence L; Vijay V; Moland CL; George N; Cao Z; Yu LR; Fuscoe JC; Beger RD; Desai VG
    J Appl Toxicol; 2016 Nov; 36(11):1486-95. PubMed ID: 26934058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early biomarkers of doxorubicin-induced heart injury in a mouse model.
    Desai VG; C Kwekel J; Vijay V; Moland CL; Herman EH; Lee T; Han T; Lewis SM; Davis KJ; Muskhelishvili L; Kerr S; Fuscoe JC
    Toxicol Appl Pharmacol; 2014 Dec; 281(2):221-9. PubMed ID: 25448438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response proteins as predictive biomarkers of doxorubicin-induced cardiotoxicity in breast cancer patients.
    Yu LR; Cao Z; Makhoul I; Daniels JR; Klimberg S; Wei JY; Bai JP; Li J; Lathrop JT; Beger RD; Todorova VK
    Exp Biol Med (Maywood); 2018 Feb; 243(3):248-255. PubMed ID: 29224368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart.
    Sun X; Zhou Z; Kang YJ
    Cancer Res; 2001 Apr; 61(8):3382-7. PubMed ID: 11309296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early transcriptional changes in cardiac mitochondria during chronic doxorubicin exposure and mitigation by dexrazoxane in mice.
    Vijay V; Moland CL; Han T; Fuscoe JC; Lee T; Herman EH; Jenkins GR; Lewis SM; Cummings CA; Gao Y; Cao Z; Yu LR; Desai VG
    Toxicol Appl Pharmacol; 2016 Mar; 295():68-84. PubMed ID: 26873546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective role of grape seed extract against doxorubicin-induced cardiotoxicity and genotoxicity in albino mice.
    Yalçin E; Oruç E; Cavuşoğlu K; Yapar K
    J Med Food; 2010 Aug; 13(4):917-25. PubMed ID: 20553142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmatic and chamber-specific modulation of cardiac microRNAs in an acute model of DOX-induced cardiotoxicity.
    Gioffré S; Ricci V; Vavassori C; Ruggeri C; Chiesa M; Alfieri I; Zorzan S; Buzzetti M; Milano G; Scopece A; Castiglioni L; Sironi L; Pompilio G; Colombo GI; D'Alessandra Y
    Biomed Pharmacother; 2019 Feb; 110():1-8. PubMed ID: 30453253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac autonomic modulation induced by doxorubicin in a rodent model of colorectal cancer and the influence of fullerenol pretreatment.
    Potočnik N; Perše M; Cerar A; Injac R; Finderle Ž
    PLoS One; 2017; 12(7):e0181632. PubMed ID: 28727839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. General oxidative stress during doxorubicin-induced cardiotoxicity in rats: absence of cardioprotection and low antioxidant efficiency of alpha-lipoic acid.
    Ghibu S; Delemasure S; Richard C; Guilland JC; Martin L; Gambert S; Rochette L; Vergely C
    Biochimie; 2012 Apr; 94(4):932-9. PubMed ID: 21396425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistance.
    Gyöngyösi M; Lukovic D; Zlabinger K; Spannbauer A; Gugerell A; Pavo N; Traxler D; Pils D; Maurer G; Jakab A; Riesenhuber M; Pircher A; Winkler J; Bergler-Klein J
    Cardiovasc Res; 2020 Apr; 116(5):970-982. PubMed ID: 31346605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes.
    Working PK; Newman MS; Sullivan T; Yarrington J
    J Pharmacol Exp Ther; 1999 May; 289(2):1128-33. PubMed ID: 10215696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
    Saad SY; Najjar TA; Alashari M
    J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of the apelin-APJ pathway in sex-related differential cardiotoxicity induced by doxorubicin in mice.
    Desai VG; Azevedo-Pouly A; Vijay V; Phanavanh B; Moland CL; Han T; Revollo J; Aryal B; Rao VA; Fuscoe JC
    J Appl Toxicol; 2023 Apr; 43(4):557-576. PubMed ID: 36227756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of mito-TEMPO against doxorubicin cardiotoxicity in mice.
    Rocha VC; França LS; de Araújo CF; Ng AM; de Andrade CM; Andrade AC; Santos Ede S; Borges-Silva Mda C; Macambira SG; Noronha-Dutra AA; Pontes-de-Carvalho LC
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):659-62. PubMed ID: 26712129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin.
    Li K; Sung RY; Huang WZ; Yang M; Pong NH; Lee SM; Chan WY; Zhao H; To MY; Fok TF; Li CK; Wong YO; Ng PC
    Circulation; 2006 May; 113(18):2211-20. PubMed ID: 16651473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin-induced delayed-onset subclinical cardiotoxicity in mice.
    Desai VG; Vijay V; Han T; Moland CL; Phanavanh B; Lee T; Davis KJ; Muskhelishvili L; Stine KC; Fuscoe JC
    J Appl Toxicol; 2022 May; 42(5):778-792. PubMed ID: 34668590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-related differences in delayed doxorubicin-induced cardiac dysfunction in C57BL/6 mice.
    Abdelgawad IY; George B; Grant MKO; Huang Y; Shan Y; Huang RS; Zordoky BN
    Arch Toxicol; 2024 Apr; 98(4):1191-1208. PubMed ID: 38244039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.